Evaluation of the sedative effects of the 3H-dexmedetomdin in the treatment of catheter ablatio
Not Applicable
- Conditions
- atrial fibrillation
- Registration Number
- JPRN-UMIN000010022
- Lead Sponsor
- niversity of Fukui Faculty of Medical Sciences, Division of cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
1)Patients with serious disoder in the central nervous system 2)Patients with muscle relaxant drug is required at catheter ablation 3)Having allergy to dexmedetomdin 4)Having allergy to alpha2 antagonist or alpha2 agonist 5)Patients who are pregnant, breastfeeding or intention to becoming pregnant 6)Patients with CHF(>NYHA III) 7)Other patients determined to be inappropriate by physician
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The time to achieve adequate sedation level was documented
- Secondary Outcome Measures
Name Time Method Heart rate, mean arterial pressure, respiratory rate, oxygen saturation, the degree of pain